Danaher Corporation : Danaher CEO Comments on Outlook

            Danaher Corporation : Danaher CEO Comments on Outlook

Washington, D.C., January 8, 2013 - Danaher Corporation (NYSE:DHR) announced
that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will
comment tomorrow on the Company's performance in a presentation at the J.P.
Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate
that the Company's fourth quarter 2012 diluted net earnings per share is
anticipated to be above the high end of the previously announced range of
$0.80-0.85, with higher than expected core revenue growth in the quarter.

Mr. Culp stated: "We are pleased by the strong finish to the year from both a
revenue and earnings perspective, which was broad-based across most of our

As previously announced, the company will hold its quarterly earnings
conference call for the fourth quarter and year-end 2012 on Tuesday, January
29, 2013 at 8:00 a.m. EST.

                                    * * *

Danaher is a science and technology leader that designs, manufactures, and
markets innovative products and services to professional, medical, industrial,
and commercial customers. Our premier brands are among the most highly
recognized in each of the markets we serve. The Danaher Business System
provides a foundation to our 59,000 associates around the world, serving
customers in more than 125 countries. In 2011, we generated $16.1 billion of
revenue. For more information please visit our website: www.danaher.com.

Statements in this release that are not strictly historical, including the
statements regarding the Company's anticipated diluted net earnings per share
and core revenue growth for the fourth quarter 2012 and any other statements
regarding events or developments that we believe or anticipate will or may
occur in the future, are "forward-looking" statements within the meaning of
the federal securities laws. There are a number of important factors that
could cause actual results, developments and business decisions to differ
materially from those suggested or indicated by such forward-looking
statements and you should not place undue reliance on any such forward-looking
statements. These factors include, among other things, deterioration of or
instability in the economy and financial markets, the impact of our
restructuring activities on our ability to grow, contractions or growth rates
and cyclicality of markets we serve, competition, our ability to develop and
successfully market new products and technologies and expand into new markets,
the potential for improper conduct by our employees, agents or business
partners, our ability to successfully identify, consummate and integrate
appropriate acquisitions (including our ability to effectively integrate the
Beckman Coulter acquisition and realize the anticipated benefits therefrom),
contingent liabilities relating to acquisitions (including our acquisition of
Beckman Coulter) and divestures, our compliance with applicable laws and
regulations (including regulations relating to medical devices and the
healthcare industry) and changes in applicable laws and regulations, our
ability to effectively address cost reduction and other changes in the
healthcare industry, risks relating to potential impairment of goodwill and
other long-lived assets, currency exchange rates, tax audits and changes in
our tax rate and income tax liabilities, litigation and other contingent
liabilities including intellectual property and environmental matters, risks
relating to product defects and recalls, the impact of our debt obligations on
our operations, our relationships with and the performance of our channel
partners, commodity costs and surcharges, our ability to adjust purchases and
manufacturing capacity to reflect market conditions, labor matters,
international economic, political, legal and business factors, risks relating
to man-made and natural disasters, pension plan costs and our non-controlling
interest in the Apex joint venture. Additional information regarding the
factors that may cause actual results to differ materially from these
forward-looking statements is available in our SEC filings, including our 2011
Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the third
quarter of 2012. These forward-looking statements speak only as of the date of
this release and the Company does not assume any obligation to update or
revise any forward-looking statement, whether as a result of new information,
future events and developments or otherwise.

Please contact:

Matt McGrew
Vice President, Investor Relations
Danaher Corporation
2200 Pennsylvania Avenue, NW
Suite 800W
Washington, D.C. 20037
Telephone: (202) 828-0850
Fax: (202) 828-0860


This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Danaher Corporation via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.